0001493152-21-003685.txt : 20210212
0001493152-21-003685.hdr.sgml : 20210212
20210212170028
ACCESSION NUMBER: 0001493152-21-003685
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KINGSLEY ALFRED D
CENTRAL INDEX KEY: 0001229339
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 21629071
MAIL ADDRESS:
STREET 1: 150 E 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
5
1
ownership.xml
X0306
5
2020-12-31
0
0
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001229339
KINGSLEY ALFRED D
C/O LINEAGE CELL THERAPEUTICS
2173 SALK AVENUE, SUITE 200
CARLSBAD,
CA
92008
1
0
0
0
Common Shares, no par value
2020-12-01
5
G
0
17500
D
5408445
D
Common Shares, no par value
1043346
I
By Corporation
Common Shares, no par value
375351
I
By LP
During December 2020, Mr. Kingsley gifted a total of 17,500 common shares.
Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.
/s/ Chase C. Leavitt, as Attorney-in-Fact
2021-02-12